Clinical Trials Browser

Adjustment Disorders, Amyotrophic Lateral Sclerosis, Anxiety Disorders, Depression, Multiple Sclerosis, Neoplasms, Idiopathic Pulmonary Fibrosis

Biliary Tract Neoplasms

Advanced Solid Tumour

Advanced Solid Tumour

Advanced Gynecological Malignancies

Prostatic Neoplasms

Advanced Solid Tumour

Advanced Solid Tumour

Biliary Tract Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Stomach Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Non-small Lung Cancer

Advanced Endometrial Cancer

Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

CLDN18.2-positive Advanced Biliary Tract Cancer

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Breast Neoplasms

Uterine Cervical Neoplasms, Recurrence

Small Cell Lung Carcinoma

Gynecological Tumors

Lymphoma, Large B-Cell, Diffuse

Glioblastoma

Breast Neoplasms

Adenocarcinoma

Extensive Stage Small Cell Lung Cancer

Nasopharyngeal Neoplasms, Recurrence

Lymphoma, Large B-Cell, Diffuse

Carcinoma, Hepatocellular

Breast Neoplasms

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

Carcinoma, Non-Small-Cell Lung

Melanoma, Sarcoma

Breast Neoplasms

Prostate Cancer Metastatic

Carcinoma, Basal Cell

Lymphoma, T-Cell, Peripheral

Biliary Tract Neoplasms

Carcinoma, Transitional Cell

Gynecological Malignancy

Carcinoma, Transitional Cell

Differentiated Thyroid Cancer

Recurrence, Lymphoma, Large B-Cell, Diffuse

Lung Neoplasms

Pancreatic Neoplasms

Gastric Adenocarcinoma

Advanced Solid Tumors

Clinical Trials

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors

A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

DVDMS

A Phase II Study of SKB571 in Patients With Lung Cancer

MK-2870-003

A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer

RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities

Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem

Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer

A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC

A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer

A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced

Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

A Study of BL-B01D1 in Patients With Recurrent Glioblastoma

Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy

Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma

Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma

The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer

KEVLARx

PREVLAR

Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations

TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors

To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer

ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer

Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma

A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer

A Study of RC48-ADC in Subjects With HER2-negative Locally Advanced or Metastatic Urothelial Cancer

A Study of RC48-ADC for the Treatment of HER2-expressing Gynecological Malignancies

A Open-label, Single-arm, Multicenter, Phase II Study of RC48-ADC to Evaluate the Efficacy and Safety of Subjects With HER2 Overexpressing Locally Advanced or Metastatic Urothelial Cancer

DTC

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients